Humans Getting Dumber Emotionally Intellectually As Species?
GO TO: goo.gl Please watch the HILARIOUS videos in this play list, read the rest of this too please. "Study suggests humans are slowly but surely losing intellectual and emotional abilities" November 12th, 2012 in Genetics In the following article, please replace the word "evolution[ary]" with "natural selection", thank you. If you have noticed the same trend, now you know others have too. Please read the entire article, as there is a silver lining, just as GD would have it of course. Human intelligence and behavior require optimal functioning of a large number of genes, which requires enormous evolutionary pressures to maintain. A provocative hypothesis published in a recent set of Science and Society pieces published in the Cell Press journal Trends in Genetics suggests that we are losing our intellectual and emotional capabilities because the intricate web of genes endowing us with our brain power is particularly susceptible to mutations and that these mutations are not being selected against in our modern society. "The development of our intellectual abilities and the optimization of thousands of intelligence genes probably occurred in relatively non-verbal, dispersed groups of peoples before our ancestors emerged from Africa," says the papers #39; author, Dr. Gerald Crabtree, of Stanford University. In this environment, intelligence was critical for survival, and there was likely to be immense selective pressure acting on the genes required for intellectual development ...From:roboecoViews:16 0ratingsTime:01:14More inEducation

See the original post:
Humans Getting Dumber Emotionally

Recommendation and review posted by Bethany Smith

Minecraft Mods Episode 433 GENETICS iPodmail 1 2 5 YouTube
Download your copy from here (Limited Time Only) http://www.mediafire.com Minecraft cracked server 1.4, NO hamachi is required to join this minecraft server. Lag Free! IP below! Tons of mods, area protections, locked chests, NPC, antigrief, giants, bonus drops, random drops, etc Lot #39;s of things are going on in this minecraft server! We have players from all over! USA, Holland, Canada, Australia, UK, etc You will have to ro sign up on the forums and post your in game name to the correct forum thread to play. Update. Sorry people. Bonuscraft server is closed. Minecraft cracked server 1.4, NO hamachi is required to join this minecraft server. Lag Free! IP below! Tons of mods, area protections, locked chests, NPC, antigrief, giants, bonus drops, random drops, etc Lot #39;s of things are going on in this minecraft server! We have players from all over! USA, Holland, Canada, Australia, UK, etc You will have to ro sign up on the forums and post your in game name to the correct forum thread to play. Update. Sorry people. Bonuscraft server is closed.From:minemaincraft1Views:0 0ratingsTime:02:42More inGaming

Read the rest here:
Minecraft Mods Episode 433 GENETICS iPodmail 1 2 5 YouTube - Video

Recommendation and review posted by Bethany Smith

Crested Gecko Genetics
some things about crested gecko geneticsFrom:Reptile KidViews:0 0ratingsTime:06:41More inPets Animals

See original here:
Crested Gecko Genetics - Video

Recommendation and review posted by Bethany Smith

Generic Genetics, Gaming PC and DAD #39;S OKAY! (UABP vlog 5)
Derp. Herpidy derp, derp. Derp. That is all for the description (that isn #39;t copy and pasted from all the others) Please leave a comment of what you think about it, I love replying to your opinions! Your support is both greatly needed and greatly appreciated! And share me my lovely UABPians! under-a-blue-pen.co.uk that #39;s where I keep all my short stories, you can request one for me to write for you, honestly I like doing it 🙂 Facebook: http://www.facebook.com Twitter: twitter.com Gmail: underabluepen@gmail.comFrom:UABPViews:0 0ratingsTime:11:12More inPeople Blogs

See the original post:
Generic Genetics, Gaming PC and DAD'S OKAY! (UABP vlog 5) - Video

Recommendation and review posted by Bethany Smith

Genetics - three20south
November 16, 2012 Sneakin Otto Through The GrottoFrom:GeneticstunesViews:1 0ratingsTime:21:16More inMusic

The rest is here:
Genetics - three20south - Video

Recommendation and review posted by Bethany Smith

The Forever Family
There are many ways to define the word "family." For some, it #39;s a bond based on shared genetics or a last name. For the Wallin family, it #39;s much more than that. Aired Nov. 15, 2012 on WKBT News 8.From:JennaTroumReporterViews:0 0ratingsTime:04:29More inPeople Blogs

See original here:
The Forever Family - Video

Recommendation and review posted by Bethany Smith

Viral Vectors Genetics Project
Wolfmother - Joker and the TheifFrom:D SchwartzViews:3 0ratingsTime:01:36More inScience Technology

See more here:
Viral Vectors Genetics Project - Video

Recommendation and review posted by Bethany Smith

The Angus Report, Nov. 19, 2012: Performance Insights
Tonya Amen of Angus Genetics Inc. explains AGI #39;s role in genetic evaluation and research, and its many contributions to the overall beef industry.From:apicreativemediaViews:1 0ratingsTime:01:52More inPets Animals

Originally posted here:
The Angus Report, Nov. 19, 2012: Performance Insights - Video

Recommendation and review posted by Bethany Smith

How To Grow Taller - My Real Life Experience Advice.mp4
Hey, guys, what #39;s up. i am creating this video to direct all of you guys who are obsessed of their height and always wishing for a miracle that will increase your height in minutes, now let me tell you even if you buy this eBook ( like rest of the countless peoples ) get all the researched steps in your hand, steps which is proven after years of research by the scientist out there. But If you are not going to correctly follow the steps in the book with needed hard work, please leave this video right now, because if you are not going to put your dedicated effort with this steps by steps course you won #39;t gain a inch and that #39;s for sure ! ( if you are in a great hurry and don #39;t want to wait, go for a surgery which will cost you thousand of dollars and a lot of pain 🙁 i don #39;t know nothing about it so, google it) Do you know ? Every passing day you loose the chances of effective height growth so i suggest you to start as quickly as possible and start doing those stretch exercises shown in the course and eat what #39;s written in that book. One of the secret fact from the ebook: every morning you height is increased a few inches that comes backs to your actual height after a few hours, why ? its because when your body is in the position of rest the spine stretches a few inches 🙂 Please don #39;t put your money in this eBook if you are above 28, it may work for some people, depending on their physic and genetics. but its just a fair advice from my side. This is the ebook course i ...From:BangonandoffViews:1 0ratingsTime:01:23More inHowto Style

Read the original here:
How To Grow Taller - My Real Life Experience

Recommendation and review posted by Bethany Smith

How to Pronounce Haldane
Learn how to say Haldane correctly with EmmaSaying #39;s "how do you pronounce" free tutorials. Definition of Haldane, JBS (oxford dictionary): (1892--1964), Scottish mathematical biologist; full name John Burdon Sanderson Haldane. As well as contributing to the development of population genetics, Haldane became well known as a popularizer of science and as an outspoken Marxist. http://www.emmasaying.comFrom:Emma SayingViews:0 0ratingsTime:00:11More inHowto Style

Read the original here:
How to Pronounce Haldane - Video

Recommendation and review posted by Bethany Smith

Breaking Down Pulmonary Embolism
When tennis star Serena Williams was treated for a pulmonary embolism, many people didn #39;t know what it was. A pulmonary embolism results when a blood clot travels from another part of the body, usually the legs, and lodges in the lungs. "The blood clot itself gets bigger and bigger until it reaches its threshold and it breaks off. Then it starts traveling through your body and it travels to the point of least resistance, smallest blood vessel, which happens to be the lungs," says Dr. Javaad Khan, a pulmonologist and critical care physician with Lee Memorial Health System. The condition not as rare as you might think Some 6 million people develop a blood clot every year, about 600-thousand of them end up with a pulmonary embolism. It can be fatal, but it is also very treatable. "If you #39;ve developed one blood clot, the treatment is usually three to six months with the blood thinners. If you have a blood disorder, which predisposes you we keep you on it for life," says Dr. Khan. A large clot can lead to heart failure, and may require an immediate delivery of clot busting drugs. "If you have heart failure, radiologists can either put a catheter directly into that vessel itself and give a clot buster from a thrombolytic type of medicine and it dissolves the clot almost instantaneously. ER physicians can also nurse that blood clotting medicine but they do it through an IV in your arm," says Dr. Khan. Pulmonary embolisms are linked to deep vein thrombosis, along with ...From:LeeMemorialMarketingViews:0 0ratingsTime:01:41More inScience Technology

Continued here:
Breaking Down Pulmonary Embolism - Video

Recommendation and review posted by Bethany Smith

The Hidden Source Episode 29 -HIDDEN HACKER?-
Myself ThatOneRebel playing some The Hidden Source! Nobody can see The Hidden only trained eyes can see him well! WATCH AS I MURDER EVERYONE AS THE HIDDEN MAHAAAHAHAHA The objective of The Hidden Source is that the humans aka IRIS must eliminate The Hidden to win vice versa for the Hidden but as the title says he is invisible and only is equipped with a knife capable of a one hit kill depending on server and only three grenades. The hidden has many abilities like taunting, super strength to ram objects into IRIS soldiers or be able to leap super high and hang on buildings. Lastly The Hidden can heal himself by eating bodies but only if they are stabbed to death not PIGSTICKED! (which is the one hit kill move) The IRIS are equipped with four weapons ranging from shotgun to rifle to SMG and a few options of equipment like senors to laser optics on your gun. Game is The Hidden Source which requires Half life 2 engine meaning you have to have Half Life 2 purchased already or another source game to run with STORYLINE In the early 1950s human genetics experimentation was taking its first, tentative steps. Amongst many other black projects, a team of British scientists working at an Infinitum Research experimental station stumbled across some remarkable phenomena involving DNA manipulation. This led to deeper research with dangerously unpredictable results, often leading to human patients losing their lives in irresponsible and immoral experiments. Time passed on, and by the mid ...From:ThatOneRebel55Views:1 0ratingsTime:11:31More inGaming

Continue reading here:
The Hidden Source Episode 29 -HIDDEN HACKER?- - Video

Recommendation and review posted by Bethany Smith

NEWARK, N.J. On April 14, 2011, James Fan stood on a parking-garage landing at Newark Liberty International Airport, a cheer-you-up letter from his young son in his pants pocket, the prospect of a four-story leap facing him.

Fan, 39, had been charged a day earlier with insider trading based on his knowledge of Seattle Genetics, a health-care company where he was manager of clinical programming. Also charged: his younger brother, Zishen, who was scheduled to take the oath of U.S. citizenship a month later.

The total take, a judge later determined, was about $200,000. James Fan was trying to help his brother, who had found himself deep under water after the California real-estate market collapsed in 2008, prosecutors said later.

The Fan case is such a cautionary tale, said Jenny Durkan, the U.S. attorney in Seattle. Both brothers were promising.

The markets are awash in insider trading, and the health-care industry has been particularly hard-hit. Health-care businesses offer illegal traders more opportunities to profit than the finance and technology sectors that have traditionally been prime victims of insiders who leaked confidential data about earnings or deals.

Health companies can live or die on the results of drug trials, which stretch for years before regulators make decisions that can trigger hundreds of millions of dollars in profits or losses. And the industry has undergone significant consolidation, leading to several multibillion-dollar mergers.

The lineup of accused health-industry insider traders illustrates how widespread the illegal practice has become: chief executive officers, hedge-fund traders, bankers, lawyers, doctors, accountants, a retired Delta Air Lines pilot, a film producer and a member of Major League Baseballs Hall of Fame have been charged or sued by regulators.

Health care is particularly attractive to criminals because so much turns on the government regulatory approval, said Rod Rosenstein, the U.S. attorney for Maryland, whose office helped prosecute the Food and Drug Administration (FDA) case. If you have a pending application for a new drug, the difference between yes and no on approvals can be tens or hundreds of millions of dollars.

The Fans are among at least 75 people sued by the Securities and Exchange Commission (SEC) or charged since 2008 with passing or receiving insider-trading tips involving pharmaceutical, biotechnology or other health care stocks.

One health-care inside trader turned informant told the FBI he was once on a golf course with three doctors whose beepers all went off at the same moment with the same inside tip.

Go here to read the rest:
Lure of riches leads to suicide in Seattle Genetics stock case

Recommendation and review posted by Bethany Smith

#39;Suicide Gene #39; Being Introduced to Moths
#39;Suicide Gene #39; Being Introduced to Moths - YouTube #9658; 3:11 #9658; 3:11 http://www.youtube.com/watch?v=5Fz1KuWaNP8 NOVO13 horas atrás - 3 min - Vídeo enviado por TheYoungTurks "Millions of GM insects developed by British scientists could be released into food crop fields without proper ... #39;Suicide Gene #39; Being Introduced to Moths - YouTube #9658; 3:11 #9658; 3:11 http://www.youtube.com/watch?v=5Fz1KuWaNP8... NOVO13 horas atrás - 3 min - Vídeo enviado por TheYoungTurks "Millions of GM insects developed by British scientists could be released into food crop fields without proper ... Mais vídeos para #39;Suicide Gene #39; Being Introduced to Moths » Action Jackson #39;s thoughts: #39;Suicide Gene #39; Being Introduced to Moths actionjackson1989.blogspot.com/.../suicide-gene... - Traduzir esta página 3 hours ago -- Cenk Uygur and Ana Kasparian discuss genetic modification to food and animals. Is engineering a moth with a #39;suicide gene #39; going too far, and ... How do you think a moth could commit suicide? - Yahoo!7 Answers au.answers.yahoo.com/question/index?... - Austrália - Traduzir esta página 1 resposta - 22 horas atrás I was reading an article that said a company was introducing a "suicide gene" into moths that plague food crops in the US O_o It didn #39;t say how ... THE STORY OF THE SUICIDE GENE - HiddenMysteries Health ... http://www.hiddenmysteries.org/.../suicidegene.html - Traduzir esta página The suicide gene is hard to trigger, but when some unknown factor does it, there is no turning back. ... Without the gene being ...From:foxnews630Views:0 0ratingsTime:03:11More inEntertainment

View original post here:
'Suicide Gene' Being Introduced to Moths - Video

Recommendation and review posted by Bethany Smith

GAINESVILLE, Fla.--(BUSINESS WIRE)--

Applied Genetic Technologies Corporation, (AGTC), a privately-held, clinical stage biotechnology company developing gene therapy products to treat rare retinal diseases, announced today that it has secured $37.5 million in a Series B round of financing.

Alta Partners and S.R. One, Limited led the financing, with new investor Osage University Partners joining existing investors InterWest, Intersouth Partners and MedImmune Ventures in the round. The funding will allow AGTC to continue development of its Phase 2 program in Alpha-1 Antitrypsin Deficiency (Alpha-1) and initiate full development of potential treatments for two orphan ophthalmology indications, Achromatopsia (ACHM) and X-Linked Rentinoschisis (XLRS).

"We are strong believers in the business model of developing treatments for genetic disorders," said Ed Hurwitz, General Partner of Alta Partners. "Based on encouraging clinical results from AGTC and others, we concluded that a large set of genetically defined diseases could be cured using AGTCs proprietary vectors and manufacturing technologies. The Series B financing is designed to move several of AGTCs programs through proof of concept as well as to allow the company to leverage its manufacturing and development infrastructure with partners to accelerate a broad portfolio of curative products.

ACHM is an inherited genetic condition that presents at birth with impaired visual acuity. Most patients are legally blind, lacking color discrimination and experiencing extreme light sensitivity, resulting in daytime blindness. ACHM is caused by mutations in a group of genes which make the cone cells concentrated in the central retina non-functional. There is no treatment for Achromatopsia, although deep red tinted spectacles or contact lenses can reduce symptoms of light sensitivity. Approximately 22,000 patients in the US and Europe suffer from this disease.

AGTCs potential treatment uses an adeno-associated virus (AAV), a safe, man-made virus that delivers healthy copies of the ACHM gene to the cells of the retina, replacing the defective copies of the gene. A single treatment is expected to halt the disease for several years, perhaps a lifetime. The AAV delivery system is successfully being used in clinical trials of Leber congenital amaurosis gene therapy that have restored vision in more than 50 adults and children who were virtually blind. Previous research has shown promising signs of efficacy in dog models of ACHM.

XLRS, an inherited genetic condition, is a leading cause of juvenile macular degeneration in males. It is caused by mutations in the RS1 gene, which results in the layers of the central retina splitting. Patients typically begin to experience progressive vision loss between the ages of 5 and 10. Other early symptoms include the inability to focus both eyes and roving, involuntary eye movements. No treatment for XLRS is currently available. Approximately 35,000 patients in the US and Europe suffer from this disease. Previous research has shown promising signs of efficacy in rodent models of XLRS.

About AGTC

AGTC is focused on the research and development of novel therapeutics for patients with unmet medical needs utilizing AGTCs proprietary, non-pathogenic adeno-associated virus (AAV) delivery system. AGTC has demonstrated that this system can be used to deliver a normal form of a gene in both animals and humans thus allowing their own body to produce sustained therapeutic levels of important biologics. The Companys most advanced programs in development are treatments for Alpha-1 antitrypsin deficiency (Alpha-1) a disease causing a progressive loss of lung function, and Lebers Congenital Amaurosis, an inherited condition causing early blindness. Both utilize AGTCs proprietary AAV system and production methods.

About Alta Partners

Read more from the original source:
AGTC Secures $37.5M Series B Funding

Recommendation and review posted by Bethany Smith

SAN DIEGO, Nov. 19, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced a winning patent decision in Europe and successful resolution of a long-standing competition between Cardium and its licensor the University of California, and Boston Scientific Corporation (BSX) and its licensor Arch Development, over rights to key methods for the application of cardiovascular gene therapy to the treatment of coronary heart disease, as is employed in Cardium's Generx gene therapy candidate currently in late-stage clinical studies. Following a decision by the European Patent Office, Cardium's patent portfolio now includes allowed and issued patents covering its gene therapy approach both in Europe and in the United States, with competing patent applications licensed and pursued by Boston Scientific having been successfully overcome in both Europe and the U.S.

(Logo:http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

The competing patent applications licensed by Boston Scientific Corporation had been filed by Dr. Jeffrey Leiden et al., currently President & CEO of Vertex Pharmaceuticals, and had been the subject of opposition proceedings in Europe and interference proceedings in the United States, both of which were ultimately resolved in favor of Cardium. Following resolution of the opposition proceedings and further examination of Cardium's case, the European Patent Office has now approved Cardium's patent application for grant in Europe. Three corresponding U.S. Patents that had been challenged by Boston Scientific Corporation (in decisions that were appealed to the United States Court of Appeals for the Federal Circuit), have been affirmed in Cardium's favor.

Cardium has additional patents and patent applications directed to its methods of cardiovascular gene therapy in the U.S., Europe, Russia and elsewhere, and the company recently filed new patent applications directed to certain improved techniques for the treatment of heart disease that are currently the subject of a Phase 3 registration trial based in Moscow, which is designed to generate additional safety and effectiveness data for the Russian Federation and other jurisdictions. Generx (alferminogene tadenovec) is intended to stimulate the growth of collateral blood vessels to effectively bypass coronary artery atherosclerotic blockages without the need for surgical procedures or angioplasty and stents; and its safety and effectiveness have been the subject of clinical studies involving more than 650 patients in the U.S., Europe and elsewhere. Generx has been assigned the trade name Cardionovo for planned commercialization in the Russian Federation. Cardium believes that its Generx clinical database represents the largest and most complete gene therapy dossier and is directed to a major medical indication that is a leading cause of death throughout the developed world.

"The resolution of these important reviews of our gene therapy patents, and the consistent decisions in our favor including rulings by the U.S. courts of appeal, underscore the value of our patent portfolio, which we believe reflects a breakthrough approach to the treatment of coronary heart disease," said Dr.TylerM.Dylan-Hyde, Chief Business Officer and General Counsel of Cardium Therapeutics.

Recently-published findings demonstrate that Cardium's innovative technique employing transient cardiac ischemia can be used to dramatically enhance gene delivery and transfection efficiency after one-time intracoronary administration of adenovector in mammalian hearts. Two consecutive but brief periods of coronary artery occlusion combined with co-administration of nitroglycerin increased both adenovector presence (measured by PCR) and transgene expression (assessed by luciferase activity) by over two orders of magnitude (>100 fold) in the heart, as compared to prior intracoronary artery delivery methods.

The research results published in Human Gene Therapy Methods extend those findings and demonstrate that Cardium's new technique for adenovector gene delivery in the heart can be used to dramatically boost adenovector delivery. By enhancing uptake even in patients with less severe forms of disease and ischemia, it would be expected to reduce response variability and allow for the potential treatment of patients with a broader range of associated coronary artery disease. The new treatment protocols for Cardium's recently-initiated ASPIRE clinical study have been developed to use this improved knowledge about induced transient ischemia techniques to enhance the non-surgical, catheter-based delivery of Generx to the heart.

Cardium has also been actively advancing its Generx product candidate's engineering and process technology in preparation for commercialization. The Company successfully transferred a refined, improved and fully-validated manufacturing process to SAFC, the custom manufacturing and services business unit of Sigma-Aldrich Corporation (SIAL), a top global specialty chemicals and biologics supplier, located in Carlsbad, California. As a result of the rigorous technical transfer process, important process improvements were achieved enabling much higher manufacturing process yields. Generx's long-term product stability has been established at a minimum of six years making it possible to manufacture product in large, cost effective batch sizes. The dose preparation process for Generx has been simplified through the integration of a fully-validated, closed-system drug transfer process incorporating the use of PhaSeal System passive safety technology to streamline and simplify the cath-lab preparation and eliminating the need to prepare Generx in a sterile, biological safety hood. The Company has also developed a new and unique, fully-validated bio-activity release assay to measure and evaluate the pro-angiogenic potency of each newly manufactured batch of Generx.

The European Commission's recent approval of uniQure's Glybera (alipogene tiparvovec) the first gene therapy approval by a major health regulatory authority is considered to represent a significant milestone and validation for the gene therapy industry.

About Generx and the ASPIRE Study

See original here:
Cardium Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease

Recommendation and review posted by Bethany Smith

Marie McCullough, Inquirer Staff Writer Posted: Monday, November 19, 2012, 3:01 AM

The first gene therapy in the Western Hemisphere will soon be available in Europe.

The approval of Glybera by European regulators happened with little fanfare in September, in contrast to the hype that surrounded gene therapy 20 years ago.

But it is truly a breakthrough for the field, for people with the ultrarare disease it treats - and for University of Pennsylvania scientist James M. Wilson, a creator of the modified virus that delivers the therapeutic gene.

Wilson began to focus on finding safe, efficient gene-delivery viruses, or vectors, after a study he led caused the 1999 death of Arizona teenager Jesse Gelsinger - the world's first gene-therapy victim.

The vector in that study triggered a fatal immune system overreaction. The fallout set off years of government investigations and efforts to improve human-subject protections.

Entertainment Today

Latest Entertainment Stories

Stay Connected

Get the latest news and events delivered to your email. Sign up now!

Excerpt from:
Gene breakthrough after sad setback

Recommendation and review posted by Bethany Smith

Mrs. Linda Flournoy
describes ger experience with Stem Cell Therapy PRPFrom:FLRegenerativeMedViews:14 0ratingsTime:02:27More inEducation

Continue reading here:
Mrs. Linda Flournoy - Video

Recommendation and review posted by simmons

Video 7 - November 14, 2012 - Adult Stem Cells Progress.wmv
Breif interview of my progress with Multiple Sclerosis with Adult Stem Cell therapy after my experience with Tysabri, Gilenya and Ampira failed.From:MSajourneyfromwithinViews:1 0ratingsTime:04:21More inEducation

Excerpt from:
Video 7 - November 14, 2012 - Adult Stem Cells Progress.wmv - Video

Recommendation and review posted by simmons

Hair Loss PRP-Stem Cell Therapy-2 month comparison- Large.m4v
http://www.newininstitute.com.au PRP Therapy was chosen instead of a Hair Transplant to treat an area of hair loss in a female. 2 month comparison Before and After photos show a highly successful outcome. Note that continued hair growth will occur over the coming months. Another procedure will need to be performed at around the peak period: 12-18 months when growth begins to slow. Newin Institute has uniquely developed processes and protocols for PRP and Adipose Stem Cell Therapy.From:Rhett BosnichViews:0 0ratingsTime:00:55More inScience Technology

Read the original here:
Hair Loss PRP-Stem Cell Therapy-2 month comparison- Large.m4v - Video

Recommendation and review posted by simmons

What Are Stem Cells and Stem Cell Therapy Stemenhance
From:Jennifer MarksViews:0 0ratingsTime:06:37More inEducation

More:
What Are Stem Cells and Stem Cell Therapy Stemenhance - Video

Recommendation and review posted by simmons

For Dr. Robert Janson-Mller, the science of fresh cell therapy is in his blood.

His grandfather, Dr. Philipp Janson was one of the few doctors who introduced the treatment in Germany. His father, Dr. Wolfgang Janson-Mller continued the work that was eventually passed on to him.

He was exposed to the revolutionary world of fresh cell therapy early on in life. The treatment uses live young cells from a donor animal like sheep to help regenerate damaged cells in the body. Dr. Mller practically grew up in his grandfather and father's clinic where he met the former's patients, some of whom still go to him for their regular treatments.

''A child always wants to grow up like his father and do the same thing. My father left it open for me. He told me I could do whatever I want, the same thing I am doing now for my daughter. I'm also head of a clinic in Munich. This is what I do besides cell treatment. We have a family practice. That is my main job,'' shares the 46-year-old German doctor who recently visited the Philippines to acquaint Filipinos with the science of fresh cell therapy.

Dr. Mller, who owns a fresh cell therapy laboratory and works as head doctor of Med Activ clinic in Munich, says that despite the growing market for it in America and Asia, there are only five doctors in Germany practicing the science. The treatment is known to deter degenerative diseases such as arthrosis, rheumatism and neurological disorders such as multiple sclerosis. But it is most popular as an anti-aging treatment. Recently, it has also been used to treat children with autism and Down syndrome.

Yet, Dr. Mller points out that fresh cell therapy is not a miracle cure for aging or these diseases. Some bodies accept the treatment while some don't. And, it doesn't treat every disease known to mankind.

Nevertheless, patients from all over the world still flock to his private clinic at the Prinzregent Hotel in Edenkoben, Germany to avail themselves of the treatment, which does not come cheap. One session would cost about $12,000 or R624,000.

''I don't treat patients with cancer, tuberculosis, AIDS, or those who are pregnant. We don't treat patients with acute inflammations like appendicitis. Aside from that, I need to see if it makes sense. If I don't see a possibility, I say no,'' he explains.

In this 60 Minutes interview, Dr. Mller shares how fresh cell therapy really works and how it can take more than just one, two, 20, 60 or even 100 treatments to get it right. Some may start as young as eight months old or continue the treatment at 99 years old. This just proves that a patient is never too young nor too old for this revolutionary treatment. (Angelo G. Garcia)

STUDENTS AND CAMPUSES BULLETIN (SCB): A lot of people are confused about the difference between stem cell and fresh cell therapy.

Link:
The cell therapist

Recommendation and review posted by simmons

Dallas Hope: Cancer Vaccine Explained
bit.ly mdash; This animation, produced by Bayer Icon Genetics in Germany, visualizes a medical first mdash;the use of tobacco leaves as delivery systems to treat follicular lymphoma. The goal is to create a patient-specific vaccine that activates the patient #39;s own immune system allowing malignant cells to be targeted and destroyed. The animation shows how recombinant DNA, cloned molecules with correct genetic information, are delivered in vitro to the tobacco leaf. The correct genetic information, represented by the blue and white cylinder, is loaded into the AgrA bacteria, the bullet which penetrates the plant tissue delivering the new genetic information to the nucleus of the plant. Then we see the nucleus releasing the transcribed genetic information into the cytoplasm, the plant #39;s cell. Within a short time, the recombinant DNA, or immunoglobulin is visible on the leaf #39;s surface, represented by the small blue white light structures. The protein is subsequently extracted from the plant leaf in very pure form. And from this harvested material, an idio type vaccine is created. Bill Bradford and others in the trial, are receiving eight doses of the vaccination, a vaccination created with their very own correct genetic information. And so what you #39;re seeing is the future of cancer treatment mdash; personalized medicine that for now will assist traditional therapies like chemotherapy and radiation. For more of Dallas Hope, visit bit.ly Check in on GetGlue via getglue.com Follow Dallas Hope ...From:baylorhealthViews:13 0ratingsTime:01:43More inEducation

Follow this link:
Dallas Hope: Cancer Vaccine Explained - Video

Recommendation and review posted by sam

Paralympic gold medallist Tom Aggar: the impact of housing s
World rowing champion, Tom Aggar, has a spinal cord injury. We showed him the shocking research findings in the report: Understanding the Health and Wellbeing of Spinal Cord Injured Adults Living in a Care Home (www.aspire.org.uk This is his response.From:Aspire CharityViews:1 0ratingsTime:01:58More inNews Politics

Go here to read the rest:
Paralympic gold medallist Tom Aggar: the impact of housing s - Video

Recommendation and review posted by sam

"Regenerating Connections that Mediate Motor Function after Spinal Cord Injury" - Dr. Oswald Steward
From:unite2fightparalysisViews:4 0ratingsTime:26:04More inScience Technology

Here is the original post:
"Regenerating Connections that Mediate Motor Function after Spinal Cord Injury" - Dr. Oswald Steward - Video

Recommendation and review posted by sam